Strepsils

From Wikipedia, the free encyclopedia
Strepsils
Strepsils brand logo
Product typeThroat lozenge
OwnerReckitt Benckiser
CountryInternational
Introduced1958; 66 years ago (1958)[1]
MarketsWorldwide
Previous ownersBoots Healthcare
Websitewww.strepsils.co.uk
Strepsils, as distributed by Zuellig Pharma in the Philippines.
A single orange Strepsils lozenge on top of a package of same flavored lozenges (circa 2017).

Strepsils is a brand of throat lozenges manufactured by British-Dutch company Reckitt Benckiser. Strepsils throat lozenges are used to relieve discomfort caused by mouth and throat infections.[2][3]

Ingredients[edit]

The primary active ingredients are dichlorobenzyl alcohol and amylmetacresol,[4] with some formulations containing ascorbic acid (vitamin C).[5] Inactive ingredients include menthol, tartaric acid, and propylene glycol.[4]

History[edit]

Strepsils was originally introduced in 1950 by Boots Healthcare as a mouthwash.[1] Strepsils throat lozenges were introduced in 1958. Strepsils was one of the Boots Healthcare brands acquired by Reckitt Benckiser in 2006.[6]

Strepsils have been in production since 1958 and contain two active ingredients, namely: amylmetacresol and 2,4-dichlorobenzyl alcohol.[7] These ingredients are mild antiseptics that can kill bacteria associated with mouth and throat infections. However, as indicated in the package, research has not demonstrated the presence of an antibacterial agent to reduce the duration or severity of an infection. Extra Strepsils contains hexylresorcinol as an active ingredient and strepsils sore throat and nose covered contains menthol 8 mg. Reckitt Benckiser also produces a higher resistance pill that used to be marketed under the Strepsils Intensive label, but is now marketed under the Strepfen brand, which contains the active ingredient flurbiprofen 8.75 mg.[7]

In Australia and Argentina also Reckitt Benckiser market Strepsils Plus, which contains lidocaine, as well as antiseptic agents present in original Strepsils. In Strepsils Spain they are also available with lidocaine marketed as Strepsils Lidocaine instead. In Hungary the Strepsils Plus also available with lidocaine.

The name of Strepsil comes from the streptococcus bacteria that causes certain types of sore throat.[8]

  • Strepsils are sold in Italy under the Benagol brand.
  • In Germany are sold now as Dobendan and Dobensana brand, from 2009 till 2013 were sold as Dobendan Strepsils.[9]
  • In Norway they are sold without active ingredients under the Repsil brand.

Dose[edit]

The recommended dose is a tablet every 2–3 hours for adults.

Vitamin C is added for Strepsils vitamin C-100. Each Strepsils Vitamin C-100 pill contains 1.2 mg of 2,4-dichlorobenzyl alcohol, Amylmetacresol 0.6 mg and 100 mg of vitamin C.

References[edit]

  1. ^ a b Reckitt Benckiser Group plc. Page accessed 28 October 2017 Strepsils - Our Health Brands
  2. ^ Weckmann G, Hauptmann-Voß A, Baumeister SE, Klötzer C, Chenot JF (2017). "Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis". Int J Clin Pract. 71 (10): 1742–1241. doi:10.1111/ijcp.13002. PMID 28869700. S2CID 23055607.
  3. ^ NHS Strepsils at NHS Choices Page accessed June 23, 2015 Archived August 17, 2014, at the Wayback Machine
  4. ^ a b "Strepsils - Summary of Product Characteristics (SPC) - (eMC)". Datapharm UK. Retrieved 2017-02-20.
  5. ^ "Strepsils Orange with Vitamin C 100mg - Summary of Product Characteristics (SPC) - (eMC)". Datapharm UK. Retrieved 2017-02-20.
  6. ^ BBC. 7 October 2005 Reckitt Benckiser buys Boots unit
  7. ^ a b Weckmann, Gesine; Hauptmann-Voß, Anke; Baumeister, Sebastian E.; Klötzer, Christine; Chenot, Jean-François (2017). "Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis". International Journal of Clinical Practice. 71 (10): e13002. doi:10.1111/ijcp.13002. ISSN 1742-1241. PMID 28869700. S2CID 23055607.
  8. ^ "Superbrands". 2011-02-19. Archived from the original on 19 February 2011. Retrieved 2022-02-15.
  9. ^ Dobendan: Besser ohne „Strepsils“. - Carolin Bauer, 24.05.2013

External links[edit]